Evidence map›Paper›PMID 35631598›Full record

ArticlePharmaceutics2022

Photothermal Therapy with HER2-Targeted Silver Nanoparticles Leading to Cancer Remission.

Victoria O Shipunova, Mariia M Belova, Polina A Kotelnikova, Olga N Shilova, Aziz B Mirkasymov, Natalia V Danilova, Elena N Komedchikova, Rachela Popovtzer, Sergey M Deyev, Maxim P Nikitin

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Electromagnetic-Thermal Coupling Competition in Ag@TiONanomaterials (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Clinical translation and landscape of silver nanoparticles.Drug delivery and translational research · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Improvement photothermal property of MoSJournal of materials science. Materials in medicine · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Victoria O ShipunovaDepartment of Nanobiomedicine, Sirius University of Science and Technology, 1 Olympic Ave., 354340 Sochi, Russia.
Mariia M BelovaDepartment of Nanobiomedicine, Sirius University of Science and Technology, 1 Olympic Ave., 354340 Sochi, Russia.
Polina A KotelnikovaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya St., 117997 Moscow, Russia.
Olga N ShilovaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya St., 117997 Moscow, Russia.
Aziz B MirkasymovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya St., 117997 Moscow, Russia.ORCID 0000-0002-1275-8535
Natalia V DanilovaFaculty of Medicine, Lomonosov Moscow State University, 27/1 Lomonosovsky Ave., 119192 Moscow, Russia.ORCID 0000-0001-7848-6707
Elena N KomedchikovaMoscow Institute of Physics and Technology, 9 Institutskiy Per., 141701 Dolgoprudny, Russia.ORCID 0000-0002-5115-3774
Rachela PopovtzerFaculty of Engineering, Institute of Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat Gan 5290002, Israel.
Sergey M DeyevShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya St., 117997 Moscow, Russia.
Maxim P NikitinDepartment of Nanobiomedicine, Sirius University of Science and Technology, 1 Olympic Ave., 354340 Sochi, Russia.
Institute of Bioorganic Chemistry · RUMoscow Institute of Physics and Technology · RUBar-Ilan University · ILLomonosov Moscow State University · RUSirius University of Science and Technology · RU

Funding

Israel Ministry of Science and Technology 3-16491Russian Foundation for Basic Research 19-515-06010Russian Science Foundation 17-74-20146
6 · The paper itself

Abstract

Nanoparticles exhibiting the localized surface plasmon resonance (LSPR) phenomenon are promising tools for diagnostics and cancer treatment. Among widely used metal nanoparticles, silver nanoparticles (Ag NPs) possess the strongest light scattering and surface plasmon strength. However, the therapeutic potential of Ag NPs has until now been underestimated. Here we show targeted photothermal therapy of solid tumors with 35 nm HER2-targeted Ag NPs, which were produced by the green synthesis using an aqueous extract of

Indexed as

affibodyAggreen synthesisHER2local hyperthermiaphotothermal therapysilver nanoparticlestargeted delivery

Identifiers

PMID35631598
PMCPMC9145338
OpenAlexW4229372534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.